Legacy Capital Partners Inc. Has $288,000 Holdings in Nutrien Ltd (NTR)
Legacy Capital Partners Inc. grew its stake in shares of Nutrien Ltd (NYSE:NTR) by 6.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,460 shares of the company’s stock after buying an additional 350 shares during the quarter. Legacy Capital Partners Inc.’s holdings in Nutrien were worth $288,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Point View Wealth Management Inc. grew its stake in shares of Nutrien by 0.9% in the fourth quarter. Point View Wealth Management Inc. now owns 26,189 shares of the company’s stock worth $1,231,000 after purchasing an additional 245 shares during the last quarter. Proficio Capital Partners LLC increased its position in Nutrien by 38.3% during the 4th quarter. Proficio Capital Partners LLC now owns 902 shares of the company’s stock valued at $42,000 after purchasing an additional 250 shares during the period. Usca Ria LLC raised its holdings in Nutrien by 1.4% in the 4th quarter. Usca Ria LLC now owns 20,676 shares of the company’s stock worth $972,000 after purchasing an additional 286 shares in the last quarter. Cetera Advisors LLC raised its holdings in Nutrien by 3.1% in the 4th quarter. Cetera Advisors LLC now owns 9,781 shares of the company’s stock worth $461,000 after purchasing an additional 293 shares in the last quarter. Finally, CLARET ASSET MANAGEMENT Corp lifted its position in shares of Nutrien by 3.7% in the 4th quarter. CLARET ASSET MANAGEMENT Corp now owns 8,583 shares of the company’s stock worth $403,000 after purchasing an additional 310 shares during the period. 66.09% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts recently issued reports on NTR shares. Barclays reissued a “buy” rating on shares of Nutrien in a research note on Sunday, February 10th. Zacks Investment Research cut shares of Nutrien from a “buy” rating to a “hold” rating in a report on Friday, January 11th. BMO Capital Markets upgraded shares of Nutrien from a “market perform” rating to an “outperform” rating in a report on Tuesday, January 8th. Raymond James reaffirmed a “strong-buy” rating and issued a $70.00 target price on shares of Nutrien in a research report on Thursday, February 7th. Finally, Morgan Stanley reissued an “equal weight” rating and set a $56.00 price target on shares of Nutrien in a research report on Wednesday, December 12th. Seven equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. Nutrien currently has a consensus rating of “Buy” and a consensus target price of $61.69.
Nutrien (NYSE:NTR) last issued its earnings results on Wednesday, February 6th. The company reported $0.54 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.54. The business had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.61 billion. Nutrien had a net margin of 18.20% and a return on equity of 12.95%. The firm’s revenue for the quarter was up 7.5% compared to the same quarter last year. As a group, analysts anticipate that Nutrien Ltd will post 3.02 EPS for the current year.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Featured Story: Understanding Analyst Recommendations
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd (NYSE:NTR).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.